These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
569 related articles for article (PubMed ID: 785094)
41. Differences in humoral immunity between a non-rejection group and a rejection group after ABO-incompatible renal transplantation. Ishida H; Tanabe K; Ishizuka T; Furusawa M; Miyamoto N; Ishikawa N; Shirakawa H; Shimmura H; Ishii D; Nozaki D; Setoguchi K; Toma H Transplantation; 2006 Mar; 81(5):665-71. PubMed ID: 16534466 [TBL] [Abstract][Full Text] [Related]
42. [Immunological analysis of human lymphocytes bearing different surface receptors]. Sidorenko SP; Iudin VM; Fedorovskaia MI; Umanskiĭ IuA Tsitologiia; 1979 Feb; 21(2):186-90. PubMed ID: 311965 [TBL] [Abstract][Full Text] [Related]
43. Monitoring and modulation of recipient immune responsiveness to prevent kidney graft rejection in the early post-transplant period. Renna E; Sansonetti P; Nesci C; Famulari A; Cortesini R Proc Eur Dial Transplant Assoc; 1977; 14():336-41. PubMed ID: 341135 [TBL] [Abstract][Full Text] [Related]
44. The formation of stable E-rosettes by human T lymphocytes activated in mixed lymphocyte reactions. Galili U; Schlesinger M J Immunol; 1976 Sep; 117(3):730-5. PubMed ID: 134120 [TBL] [Abstract][Full Text] [Related]
45. Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections. Chisari FV; Routenberg JA; Edgington TS J Clin Invest; 1976 May; 57(5):1227-38. PubMed ID: 1083396 [TBL] [Abstract][Full Text] [Related]
46. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy. Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463 [TBL] [Abstract][Full Text] [Related]
47. Immunological characteristics of lymphocytes in synovial fluid and peripheral blood in patients with rheumatoid arthritis. Michałkiewicz J Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):801-5. PubMed ID: 312088 [TBL] [Abstract][Full Text] [Related]
48. Separation and properties of EA-rosette-forming lymphocytes in humans. van Oers MH; Zeijlemaker WP; Schellekens PT Eur J Immunol; 1977 Mar; 7(3):143-50. PubMed ID: 324774 [TBL] [Abstract][Full Text] [Related]
49. Immunologic heterogeneity of the lymphocyte surface in various diseases. Nowak J; Horst A Ann Med Sect Pol Acad Sci; 1975; 20(3):173-84. PubMed ID: 1103513 [TBL] [Abstract][Full Text] [Related]
50. Two-color flow cytometry and functional analysis of lymphocytes cultured from human renal allografts: identification of a Leu-2+3+ subpopulation. Preffer FI; Colvin RB; Leary CP; Boyle LA; Tuazon TV; Lazarovits AI; Cosimi AB; Kurnick JT J Immunol; 1986 Nov; 137(9):2823-30. PubMed ID: 3093583 [TBL] [Abstract][Full Text] [Related]
51. Comparison of the relative cytotoxic effector cell capabilities and the proportions of cells bearing various surface markers in human tonsil and peripheral blood mononuclear cells. Hunninghake GW; Haynes BF; Parrillo JE; Fauci AS Clin Exp Immunol; 1978 Apr; 32(1):186-91. PubMed ID: 668191 [TBL] [Abstract][Full Text] [Related]
52. Immunodetection of lymphocyte subpopulations involved in allograft rejection in a teleost, Dicentrarchus labrax (L.). Abelli L; Baldassini MR; Mastrolia L; Scapigliati G Cell Immunol; 1999 Feb; 191(2):152-60. PubMed ID: 9973538 [TBL] [Abstract][Full Text] [Related]
53. PHA stimulation of separated human lymphocyte populations. Potter MR; Moore M Clin Exp Immunol; 1975 Sep; 21(3):456-67. PubMed ID: 1106926 [TBL] [Abstract][Full Text] [Related]
54. Rosette-formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes. Gupta S; Good RA; Siegal FP Clin Exp Immunol; 1976 Aug; 25(2):319-27. PubMed ID: 1085238 [TBL] [Abstract][Full Text] [Related]
55. T and B membrane markers on blast cells in 69 patients with acute lymphoblastic leukemia. Brouet JC; Toben HR; Chevalier A; Seligmann M Ann Immunol (Paris); 1974; 125 C(5):691-6. PubMed ID: 4617552 [No Abstract] [Full Text] [Related]
56. The presence of B-cell nodules does not necessarily portend a less favorable outcome to therapy in patients with acute cellular rejection of a renal allograft. Doria C; di Francesco F; Ramirez CB; Frank A; Iaria M; Francos G; Marino IR; Farber JL Transplant Proc; 2006 Dec; 38(10):3441-4. PubMed ID: 17175297 [TBL] [Abstract][Full Text] [Related]
57. Characterization of feline T and B cells. Kuramochi T; Takeishi M; Ishida T; Kato K; Ishida M Am J Vet Res; 1987 Feb; 48(2):183-5. PubMed ID: 3493718 [TBL] [Abstract][Full Text] [Related]
58. Tubulitis in renal allograft rejection: role of transforming growth factor-beta and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells. Wong WK; Robertson H; Carroll HP; Ali S; Kirby JA Transplantation; 2003 Feb; 75(4):505-14. PubMed ID: 12605119 [TBL] [Abstract][Full Text] [Related]
59. Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. I. Surface markers and K cell activity after separation of B cells and lymphocytes and Fc-receptors by column fractionation. Pape GR; Troye M; Perlmann P J Immunol; 1977 Jun; 118(6):1919-24. PubMed ID: 325129 [No Abstract] [Full Text] [Related]
60. Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells. West WH; Cannon GB; Kay HD; Bonnard GD; Herberman RB J Immunol; 1977 Jan; 118(1):355-61. PubMed ID: 299761 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]